Bank Of America Corp Zentalis Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,130,092 shares of ZNTL stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,130,092

Previous 215,999 423.19%

Holding current value

$1.62 Million

Previous $654,000 174.62%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.59 - $3.24 $1.45 Million - $2.96 Million	914,093 Added 423.19%	1,130,092 $1.8 Million
Q4 2024 Feb 14, 2025	SELL	$2.7 - $4.03 $1.51 Million - $2.25 Million	-559,537 Reduced 72.15%	215,999 $654,000
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $775,178 - $1.22 Million	267,303 Added 52.59%	775,536 $2.85 Million
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $132,012 - $520,628	32,277 Added 6.78%	508,233 $2.08 Million
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $2.63 Million - $4 Million	-242,687 Reduced 33.77%	475,956 $7.5 Million
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $4.46 Million - $9.12 Million	453,159 Added 170.69%	718,643 $10.9 Million
Q2 2023 Aug 14, 2023	SELL	$17.41 - $30.05 $605,972 - $1.05 Million	-34,806 Reduced 11.59%	265,484 $7.49 Million
Q1 2023 May 12, 2023	BUY	$16.14 - $24.94 $967,593 - $1.5 Million	59,950 Added 24.94%	300,290 $5.16 Million
Q4 2022 Feb 10, 2023	BUY	$18.07 - $25.6 $2.14 Million - $3.03 Million	118,205 Added 96.78%	240,340 $4.84 Million
Q3 2022 Nov 14, 2022	SELL	$20.23 - $31.73 $3.79 Million - $5.94 Million	-187,332 Reduced 60.53%	122,135 $2.65 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $451,672 - $1.32 Million	25,219 Added 8.87%	309,467 $8.7 Million
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $3.61 Million - $7.03 Million	86,859 Added 44.0%	284,248 $13.1 Million
Q4 2021 Feb 08, 2022	BUY	$66.92 - $84.79 $7.56 Million - $9.58 Million	113,038 Added 134.01%	197,389 $16.6 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $118,198 - $185,514	2,524 Added 3.08%	84,351 $5.62 Million
Q2 2021 Sep 13, 2021	BUY	$37.41 - $62.25 $3.06 Million - $5.09 Million	81,827 New	81,827 $4.35 Million

Others Institutions Holding ZNTL

# of Institutions

139

Shares Held

61.2M

Call Options Held

7.9K

Put Options Held

42.5K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $81.5M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Zentalis Pharmaceuticals, Inc. Transaction History